METHOD FOR DETERMINING SITE FOR IMPLANTATION OF VENTRICULAR ELECTRODES OF CARDIAC CONTRACTILITY MODULATION DEVICE IN PATIENTS WITH CHRONIC HEART FAILURE
2022-12-05
专利权人FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期2022-12-05
专利号RU2806973-C1
成果简介NOVELTY - Used in cardiac surgery to determine the optimal zone for implantation of ventricular electrodes (VE) of a cardiac contractility modulation (CCM) device in patients with chronic heart failure (CHF). Based on the data of myocardial perfusion scintigraphy with 99m Tc-MIBI at rest, the perfusion of the anterior and inferior septal regions of the LV is assessed. VEs are implanted into the basal, middle or apical segments of the anterior and inferior septal regions of the left ventricle (LV) if the degree of perfusion impairment is 2 points or less on a 5-point scale and the intensity of radiopharmaceutical accumulation is at least 30%. USE - Cardiovascular surgery. ADVANTAGE - Increasing the effectiveness of cardiac contractility modulation therapy, leading to more significant reverse myocardial remodeling. 1 cl, 4 dwg
IPC 分类号A61B-006/03 ; A61N-001/05
国家俄罗斯
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/22426
专题中国科学院新疆生态与地理研究所
作者单位
FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式
GB/T 7714
SAFIULLINA A A,TERESHCHENKO S N,SAPELNIKOV O V,et al. METHOD FOR DETERMINING SITE FOR IMPLANTATION OF VENTRICULAR ELECTRODES OF CARDIAC CONTRACTILITY MODULATION DEVICE IN PATIENTS WITH CHRONIC HEART FAILURE. RU2806973-C1[P]. 2022.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。